294 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
MASI Masimo Corporation $121 $6.31B Downtrend
Article Searches
Interview: Talking Decking, Diets, and Discounts With the Polen Small Company Growth Team https://www.fool.com/investing/2019/04/18/interview-decking-diets-and-discounts-with-the-pol.aspx?source=iedfolrf0000001 Apr 18, 2019 - John talks to Tucker Walsh and Rayna Lesser Hannaway, the two portfolio managers of the Polen U.S. Small Company Growth Strategy, about Paycom, EPAM Systems, and more.
Here's Why You Should Buy Masimo (MASI) Stock Right Now http://www.zacks.com/stock/news/382320/heres-why-you-should-buy-masimo-masi-stock-right-now?cid=CS-ZC-FT-382320 Apr 16, 2019 - Masimo (MASI) has been benefitting from developments like the FDA clearance of the Rad-67 Pulse CO-Oximeter.
Here's Why Investors Should Retain Accuray (ARAY) Stock Now http://www.zacks.com/stock/news/378512/heres-why-investors-should-retain-accuray-aray-stock-now?cid=CS-ZC-FT-378512 Apr 11, 2019 - Management at Accuray (ARAY) sees significant opportunities in China.
Here's Why You Should Buy Varian Medical (VAR) Stock Now http://www.zacks.com/stock/news/377016/heres-why-you-should-buy-varian-medical-var-stock-now?cid=CS-ZC-FT-377016 Apr 10, 2019 - Varian Medical (VAR) announces the installation of cyclotron for its ProBeam proton therapy system at the Hefei Ion Medical Center in China.
Here's Why You Should Hold Becton, Dickinson Stock for Now http://www.zacks.com/stock/news/371385/heres-why-you-should-hold-becton-dickinson-stock-for-now?cid=CS-ZC-FT-371385 Apr 05, 2019 - Becton, Dickinson (BDX) announces the FDA premarket approval for Venovo venous stent device.
ABIOMED Impella Data Show Significant Rise in Survival Rates http://www.zacks.com/stock/news/371284/abiomed-impella-data-show-significant-rise-in-survival-rates?cid=CS-ZC-FT-371284 Apr 05, 2019 - ABIOMED (ABMD) plans to expand products like Impella CP, Impella Connect, Impella 5.5 and Impella RP.
Masimo Gets FDA Clearance for Rad-67 Monitoring Device http://www.zacks.com/stock/news/364697/masimo-gets-fda-clearance-for-rad-67-monitoring-device?cid=CS-ZC-FT-364697 Mar 26, 2019 - The clearance will enable Masimo (MASI) to provide portable spot-checking monitoring measurements of oxygen saturation and non-invasive hemoglobin.
Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip http://www.zacks.com/stock/news/364388/thermo-fisher-to-buy-brammer-bio-tightens-gene-therapy-grip?cid=CS-ZC-FT-364388 Mar 25, 2019 - On closure of the acquisition deal, Brammer Bio will be integral to Thermo Fisher's (TMO) pharma services business within its Laboratory Products and Services wing.
Quest Diagnostics Grows on New Pacts Amid Reimbursement Issue http://www.zacks.com/stock/news/364204/quest-diagnostics-grows-on-new-pacts-amid-reimbursement-issue?cid=CS-ZC-FT-364204 Mar 25, 2019 - Quest Diagnostics' (DGX) partnership with UnitedHealthcare to operate as a preferred national laboratory seems strategic for the latter's customers.
Varian (VAR) Scales New 52-Week High on Solid Prospects http://www.zacks.com/stock/news/363525/varian-var-scales-new-52-week-high-on-solid-prospects?cid=CS-ZC-FT-363525 Mar 22, 2019 - The key growth driving factor for Varian (VAR) in the past year has been increasing net sales from major business segments.

Pages: 123456...30

Page 1>